Analyst updates happen on news release days Why no analyst updates? Because they already knew this news from June 4, 2021.
There is nothing new to report here after they pulled their 2 key lead indications being planned in phase 2 trials in H2/21. Liminal has not identified a single market that they will chase so analysts have no idea what to base a valuation on except some preclinical data worth $3.8M as bought by Galbraith to enrich himself. it's a sad story and thomvest / management clearly have an agenda to have nothing in their story/milestones so uncertainty will drive share price to zero as cash gets spent on bloated salaries of the mgmt. Very sad